These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 8759718)
41. MRC OX-2 defines a novel T cell costimulatory pathway. Borriello F; Lederer J; Scott S; Sharpe AH J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466 [TBL] [Abstract][Full Text] [Related]
42. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells. Hauss P; Selz F; Cavazzana-Calvo M; Fischer A Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116 [TBL] [Abstract][Full Text] [Related]
43. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin. Mukherjee S; Maiti PK; Nandi D J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713 [TBL] [Abstract][Full Text] [Related]
44. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Muraille E; De Smedt T; Thielemans K; Urbain J; Moser M; Leo O Cell Immunol; 1995 May; 162(2):315-20. PubMed ID: 7538050 [TBL] [Abstract][Full Text] [Related]
46. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4. Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977 [TBL] [Abstract][Full Text] [Related]
47. The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigens. Blankson JN; Morse SS Cell Immunol; 1994 Aug; 157(1):306-12. PubMed ID: 7518754 [TBL] [Abstract][Full Text] [Related]
48. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation. Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221 [TBL] [Abstract][Full Text] [Related]
49. Costimulation of CD28- T lymphocytes by 4-1BB ligand. DeBenedette MA; Shahinian A; Mak TW; Watts TH J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967 [TBL] [Abstract][Full Text] [Related]
50. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. Blotta MH; Marshall JD; DeKruyff RH; Umetsu DT J Immunol; 1996 May; 156(9):3133-40. PubMed ID: 8617933 [TBL] [Abstract][Full Text] [Related]
51. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. Norton SD; Zuckerman L; Urdahl KB; Shefner R; Miller J; Jenkins MK J Immunol; 1992 Sep; 149(5):1556-61. PubMed ID: 1380533 [TBL] [Abstract][Full Text] [Related]
52. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. Nandi D; Gross JA; Allison JP J Immunol; 1994 Apr; 152(7):3361-9. PubMed ID: 7511644 [TBL] [Abstract][Full Text] [Related]
53. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand. Jones KW; Hackett CJ Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453 [TBL] [Abstract][Full Text] [Related]
54. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity. Wong SC; Tan AH; Lam KP Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753 [TBL] [Abstract][Full Text] [Related]
55. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372 [TBL] [Abstract][Full Text] [Related]
56. CD40 can costimulate human memory T cells and favors IL-10 secretion. Rogers NJ; Jackson IM; Jordan WJ; Lombardi G; Delikouras A; Lechler RI Eur J Immunol; 2003 Apr; 33(4):1094-104. PubMed ID: 12672076 [TBL] [Abstract][Full Text] [Related]